{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:36:37Z","timestamp":1777952197531,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pretransplant vaccination is generally recommended to solid organ transplant recipients. In infants with congenital nephrotic syndrome (CNS), the immune response is hypothetically inferior to other patients due to young age and urinary loss of immunoglobulins, but data on the immunization response in severely nephrotic children remain scarce. If effective, however, early immunization of infants with CNS would clinically be advantageous.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated serological vaccine responses in seven children with CNS who were immunized during nephrosis. Antibody responses to measles-mumps-rubella -vaccine (MMR), a pentavalent DTaP-IPV-Hib -vaccine (diphtheria, tetanus, acellular pertussis, inactivated poliovirus, <jats:italic>Haemophilus influenzae<\/jats:italic> type b), varicella vaccine, combined hepatitis A and B vaccine, and pneumococcal conjugate vaccine (PCV) were measured after nephrectomy either before or after kidney transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Immunizations were started at a median age of 7 months [interquartile range (IQR) 7\u20138], with a concurrent median proteinuria of 36,500\u2005mg\/L (IQR 30,900\u201364,250). Bilateral nephrectomy was performed at a median age of 20 months (IQR 14\u201325), and kidney transplantation 10\u201388 days after the nephrectomy. Antibody levels were measured at median 18 months (IQR 6\u201323) after immunization. Protective antibody levels were detected in all examined children for hepatitis B (5\/5), <jats:italic>Clostridium tetani<\/jats:italic> (7\/7), rubella virus (2\/2), and mumps virus (1\/1); in 5\/6 children for varicella; in 4\/6 for poliovirus and vaccine-type pneumococcal serotypes; in 4\/7 for <jats:italic>Haemophilus influenzae<\/jats:italic> type B and <jats:italic>Corynebacterium diphtheriae<\/jats:italic>; in 1\/2 for measles virus; and in 2\/5 for hepatitis A. None of the seven children had protective IgG levels against <jats:italic>Bordetella pertussis<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Immunization during severe congenital proteinuria resulted in variable serological responses, with both vaccine- and patient-related differences. Nephrosis appears not to be a barrier to successful immunization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1392873","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:45:46Z","timestamp":1714657546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Serological responses to immunization during nephrosis in infants with congenital nephrotic syndrome of the Finnish type"],"prefix":"10.3389","volume":"12","author":[{"given":"Okko","family":"Savonius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Kaskinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"H\u00f6ltt\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Ylinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juuso","family":"Tainio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tea","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"AST ID community of practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1399-3046.2011.01593.x","article-title":"An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient","volume":"15","author":"Abuali","year":"2011","journal-title":"Pediatr Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00467-007-0633-9","article-title":"Congenital nephrotic syndrome","volume":"24","author":"Jalanko","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41581-020-00384-1","article-title":"Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN working group","volume":"17","author":"Boyer","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1046\/j.1523-1755.2000.00254.x","article-title":"Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients","volume":"58","author":"Patrakka","year":"2000","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/petr.12686","article-title":"The second report of the nordic pediatric renal transplantation registry 1997\u20132012: more infant recipients and improved graft survivals","volume":"20","author":"Jahnukainen","year":"2016","journal-title":"Pediatr Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00858984","article-title":"Management of congenital nephrotic syndrome of the Finnish type","volume":"9","author":"Holmberg","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s00467-022-05835-4","article-title":"Vaccines and nephrotic syndrome: efficacy and safety","volume":"38","author":"Angeletti","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s13312-021-2161-2","article-title":"Seroprotection for diphtheria, Pertussis, tetanus and measles in children with nephrotic syndrome","volume":"58","author":"Ajay","year":"2021","journal-title":"Indian Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0950268802007896","article-title":"Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis","volume":"129","author":"Teunis","year":"2002","journal-title":"Epidemiol Infect"},{"key":"B11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/21645515.2016.1259780","article-title":"Immune persistence after pertussis vaccination","volume":"13","author":"Chen","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.vaccine.2010.12.033","article-title":"Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins","volume":"29","author":"Hendrikx","year":"2011","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1432-2277.2009.01030.x","article-title":"Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation","volume":"23","author":"Urschel","year":"2010","journal-title":"Transpl Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e13490","DOI":"10.1111\/petr.13490","article-title":"Measles, mumps, rubella (vaccine) and varicella vaccines in pediatric liver transplant: an initial analysis of post-transplant immunity","volume":"23","author":"Yoeli","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e14322","DOI":"10.1111\/petr.14322","article-title":"Low post-transplant measles and varicella titers among pediatric liver transplant recipients: a 10-year single-center study","volume":"26","author":"Liman","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/TP.0b013e3182743d57","article-title":"Course of immunization titers after pediatric kidney transplantation and association with glomerular filtration rate and kidney function","volume":"94","author":"Beil","year":"2012","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e4738","DOI":"10.1097\/MD.0000000000004738","article-title":"Waning of vaccine-induced immunity to measles in kidney transplanted children","volume":"95","author":"Rocca","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e14577","DOI":"10.1111\/ctr.14577","article-title":"Vaccination in pediatric solid organ transplant: a primer for the immunizing clinician","volume":"36","author":"Chen","year":"2022","journal-title":"Clin Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/tid.13343","article-title":"A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients","volume":"22","author":"Eriksson","year":"2020","journal-title":"Transpl Infect Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1392873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:45:49Z","timestamp":1714657549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1392873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":20,"alternative-id":["10.3389\/fped.2024.1392873"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1392873","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"article-number":"1392873"}}